Medindia

X

CrimsonLogic Simplifies Food and Drug Imports to North America with New Platform

Thursday, October 20, 2016 Drug News J E 4
Advertisement
Accelerates global trade by increasing efficiency in getting accurate information to authorities

TORONTO, Oct. 20, 2016 /PRNewswire/ -- Global eTrade Services (GeTS), the subsidiary of CrimsonLogic, a leading provider of eGovernment products and services, has launched the Food and Drug Administration (FDA) Prior Notice (PN) System Interface (SI). The web-based solution is designed to simplify and streamline food and drug imports into the United States (US).

The United States is the world's second biggest importer and Canada is the second largest goods trading partner with US$575 billion in total (two way) goods trade during 2015. Canada is also the largest supplier of agricultural imports to the US, with imports valued at US$22 billion in 2015[1]. The launch of the GeTS FDA PNSI platform is expected to simplify food and related shipments enabling greater security in global supply chains by reducing trade risk and increase efficiency. 

Mr Eugene Wong, Chairman of CrimsonLogic said: "As a subsidiary of CrimsonLogic, GeTS aims to accelerate global trade through worldwide connectivity. The addition of GeTS FDA PNSI brings us a step closer to our goal of building a global Single Window, by offering a comprehensive suite of online, on-demand trade facilitation services that helps exporters and importers meet the regulatory and compliance requirements for countries around the world."

The platform offers CrimsonLogic customers an easy way to upload information required by the FDA ahead of shipments reaching port and customs authorities. The requirement to disclose shipment information applies to the import of food (for both human and animal consumption) into or through the United States. With simplified access and the ability to view and track responses from FDA directly, it enables businesses to save time in manual upload of information and ensure minimal shipment delays.

As a pioneer of Single Window systems, CrimsonLogic has worked with governments in more than 16 countries to streamline their trade processes, increasing efficiency and enhancing trade competitiveness. More than 5,000 customers globally use CrimsonLogic services to facilitate global trade transactions; more than 20% of highway shipments crossing the US-Canada border use CrimsonLogic systems.

For media enquiries, please contact:

Francis HuanCrimsonLogic / Global eTrade ServicesTel: +65 6887 7173Mobile: +65 9820 5994Email: francishuan@crimsonlogic.com

About Global eTrade Services (GeTS)

Global eTrade Services (GeTS) is a CrimsonLogic subsidiary and a key growth engine for the Group.  GeTS has a comprehensive suite of services that helps traders meet regulatory and compliance requirements from Government agencies and trade associations around the world.  Based on a SaaS model, GeTS is centered on a Single Window (SW) that facilitates global trade with Compliance Connectivity, eAdvisory and Data Analytics suite of services.

About CrimsonLogic

CrimsonLogic is a trusted partner to governments. For more than 25 years, CrimsonLogic has worked with governments around the world to find innovative and sustainable solutions to collaborate more seamlessly with their citizens. The company has continued to set industry-standards by delivering world-first eGovernment solutions. CrimsonLogic provides end-to-end services, from designing to operating these services to drive substantial and lasting improvements. For more information, please visit www.crimsonlogic.com.

[1] Source: Office of the United States Trade Representative

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/crimsonlogic-simplifies-food-and-drug-imports-to-north-america-with-new-platform-300348428.html

SOURCE CrimsonLogic

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
New compound shows promise in treating multiple hu...
S
Anti-MUC1 MAb AR20.5 Induces Specific Cell Mediate...